Zhibao Technology Launches Joint Venture With Yingshi Health to Develop Medical Insurance Products

Reuters
Dec 17, 2025
Zhibao Technology Launches Joint Venture With Yingshi Health to Develop Medical Insurance Products

Zhibao Technology Inc., a leading InsurTech company, has announced the commencement of operations for Shanghai Zhibao Yingshi Health Technology Co. Ltd (Zhibao Yingshi), a joint venture formed in September 2025 with Yingshi Health, a subsidiary of Shanghai Xingtao Network Technology Co. Ltd. Under the terms of the Cooperation Framework Agreement, Zhibao Technology holds a 51% equity interest in the new venture, which aims to accelerate the development of medical insurance products in China. The partnership combines Zhibao's expertise in digital insurance brokerage and reinsurance with Yingshi Health's presence in the mid-end medical insurance market. Preliminary revenue targets have been set at RMB 4 million per month for the remainder of 2025 and RMB 50 million for 2026, with annual growth expected to be no less than 10%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhibao Technology Inc. published the original content used to generate this news brief on December 17, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10